What is the share price of Fabtech Technologies Ltd (FABTECH) today?
The share price of FABTECH as on 5th December 2025 is ₹243.54. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fabtech Technologies Ltd (FABTECH) share?
The past returns of Fabtech Technologies Ltd (FABTECH) share are- Past 1 week: -3.59%
- Past 1 month: -1.61%
- Past 3 months: N/A%
- Past 6 months: 33.52%
- Past 1 year: 33.52%
- Past 3 years: N/A%
- Past 5 years: 33.52%
What are the peers or stocks similar to Fabtech Technologies Ltd (FABTECH)?
The peers or stocks similar to Fabtech Technologies Ltd (FABTECH) include:What is the market cap of Fabtech Technologies Ltd (FABTECH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fabtech Technologies Ltd (FABTECH) is ₹1082.55 Cr as of 5th December 2025.What is the 52 week high and low of Fabtech Technologies Ltd (FABTECH) share?
The 52-week high of Fabtech Technologies Ltd (FABTECH) is ₹262.80 and the 52-week low is ₹173.28.What is the PE and PB ratio of Fabtech Technologies Ltd (FABTECH) stock?
The P/E (price-to-earnings) ratio of Fabtech Technologies Ltd (FABTECH) is 23.31. The P/B (price-to-book) ratio is 6.25.Which sector does Fabtech Technologies Ltd (FABTECH) belong to?
Fabtech Technologies Ltd (FABTECH) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Fabtech Technologies Ltd (FABTECH) shares?
You can directly buy Fabtech Technologies Ltd (FABTECH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fabtech Technologies Ltd
FABTECH Share Price
FABTECH Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
FABTECH Performance & Key Metrics
FABTECH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 32.92 | 6.25 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.87 | 5.82 | 0.59% |
FABTECH Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
FABTECH Company Profile
Fabtech Technologies Ltd offers end-to-end pharmaceutical engineering solutions including cleanroom infrastructure, granulation, isolator containment, HVAC, and packaging lines across pharma, biotech, and healthcare sectors.
FABTECH Sentiment Analysis
FABTECH Sentiment Analysis
FABTECH Stock Summary · November 2025
The company demonstrated robust financial performance with significant year-on-year growth in income and net profit, supported by a strong order book and a focus on high-value turnkey projects in emerging markets. However, challenges in operational efficiency persist, particularly in managing working capital and receivable cycles, which could impact cash flow. Despite these hurdles, management remains optimistic about future growth, particularly in the MENA region's pharmaceutical market, where substantial investments are driving demand. The strategic emphasis on compliance and quality positions the company favorably for long-term client relationships and market expansion. While EBITDA margins have shown variability, a commitment to structural efficiencies and high-margin projects is expected to sustain profitability amidst market dynamics.
FABTECH Stock Growth Drivers
FABTECH Stock Growth Drivers
6Strong Financial Performance
Fabtech Technologies Limited reported impressive financial results for the first half of FY '26, achieving
Robust Order Book and Project Pipeline
As of July 31, 2025, Fabtech Technologies maintained a strong order book valued at INR
FABTECH Stock Challenges
FABTECH Stock Challenges
3Inconsistent EBITDA Performance
The company's project-based business model has led to inconsistent EBITDA performance, with fluctuations that hinder
Challenges in Revenue Breakdown
The company faces difficulties in providing a detailed revenue breakdown across different segments due to
FABTECH Forecast
FABTECH Forecasts
FABTECH
FABTECH
Income
Balance Sheet
Cash Flow
FABTECH Income Statement
FABTECH Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 138.08 | 122.81 | 261.15 | 203.55 | 231.99 | 354.11 | 305.32 | |||||||
| Raw Materials | 63.86 | 67.30 | 135.93 | 102.37 | 121.50 | 212.20 | 256.28 | |||||||
| Power & Fuel Cost | 0.14 | 0.07 | 0.09 | 0.14 | 0.16 | 0.25 | ||||||||
| Employee Cost | 16.62 | 11.77 | 18.23 | 19.11 | 19.78 | 34.34 | ||||||||
| Selling & Administrative Expenses | 11.75 | 13.91 | 41.32 | 37.21 | 33.65 | 46.94 | ||||||||
| Operating & Other expenses | 26.84 | 16.88 | 29.46 | 9.85 | 16.20 | -5.83 | ||||||||
| EBITDA | 18.87 | 12.88 | 36.12 | 34.87 | 40.70 | 66.21 | 49.04 | |||||||
| Depreciation/Amortization | 0.49 | 0.50 | 1.62 | 1.90 | 2.08 | 2.61 | 3.99 | |||||||
| PBIT | 18.38 | 12.38 | 34.50 | 32.97 | 38.62 | 63.60 | 45.05 | |||||||
| Interest & Other Items | 2.23 | 1.60 | 3.12 | 5.06 | 2.84 | 3.17 | 2.99 | |||||||
| PBT | 16.15 | 10.78 | 31.38 | 27.91 | 35.78 | 60.43 | 42.06 | |||||||
| Taxes & Other Items | 3.76 | 2.73 | 7.91 | 6.16 | 8.55 | 13.98 | 9.18 | |||||||
| Net Income | 12.39 | 8.05 | 23.47 | 21.75 | 27.23 | 46.45 | 32.88 | |||||||
| EPS | 1,126.36 | 731.82 | 15.26 | 7.10 | 8.64 | 14.34 | 10.15 | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FABTECH Company Updates
Investor Presentation
FABTECH Stock Peers
FABTECH Past Performance & Peer Comparison
FABTECH Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fabtech Technologies Ltd | 23.31 | 6.25 | — |
| Sun Pharmaceutical Industries Ltd | 39.63 | 5.98 | 0.89% |
| Torrent Pharmaceuticals Ltd | 67.04 | 16.88 | 0.85% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
FABTECH Stock Price Comparison
Compare FABTECH with any stock or ETFFABTECH Holdings
FABTECH Shareholdings
FABTECH Promoter Holdings Trend
FABTECH Promoter Holdings Trend
Pledged promoter holdings is insignificant
FABTECH Institutional Holdings Trend
FABTECH Institutional Holdings Trend
No institutional holdings trend are available
FABTECH Shareholding Pattern
FABTECH Shareholding Pattern
FABTECH Shareholding History
FABTECH Shareholding History
smallcases containing FABTECH stock
smallcases containing FABTECH stock
Looks like this stock is not in any smallcase yet.
FABTECH Events
FABTECH Events
FABTECH Dividend Trend
FABTECH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
FABTECH Dividend Trend
FABTECH has not given any dividends in last 5 years
FABTECH Dividends
FABTECH Dividends
FABTECH Stock News & Opinions
FABTECH Stock News & Opinions
Fabtech Technologies has secured an order/contract worth USD 7.8 million (approximately Rs 65.52 crore) with One of the Leading companies in Saudi Arabia working in partnership with a multi-national company from Argentina. Powered by Capital Market - Live
Fabtech Technologies has secured a project worth Rs 52 crore to establish a veterinary medicines manufacturing facility in the Maghreb region in North Africa. Powered by Capital Market - Live
KP Group, has entered into a Memorandum of Understanding (MoU) with Fabtech Group to collaboratively develop and implement green energy powered life sciences projects globally. Under this partnership, all such projects executed by Fabtech Group (conventional/stick-built) will be powered by clean, renewable energy supplied by KP Group across the world. Under this strategic collaboration, KP Group will provide and integrate solar, wind, hybrid, Ba ery Energy Storage System (BESS) and green hydrogen-based power solutions for Fabtech Group's conventional, pharma, biotech and healthcare solutions. The initiative aims to create a new genera on of sustainable, and low-carbon digital ecosystems - worldwide. Both groups will work together to design and deploy green-powered pilot and demonstration projects and explore commercial rollouts and global deployment opportunities for renewable-energy-based infrastructure. The partnership represents a significant step towards carbon-neutral digital transformation and aligns with our commitment to sustainable infrastructure development.Powered by Capital Market - Live
Net profit of Fabtech Technologies rose 449.02% to Rs 28.11 crore in the quarter ended September 2025 as against Rs 5.12 crore during the previous quarter ended September 2024. Sales rose 106.81% to Rs 121.48 crore in the quarter ended September 2025 as against Rs 58.74 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales121.4858.74 107 OPM %25.077.81 - PBDT32.576.71 385 PBT31.266.01 420 NP28.115.12 449 Powered by Capital Market - Live
Fabtech Technologies has postponed the meeting of the Board of Directors which was scheduled to be held on 23 October 2025. The meeting will now be held on 27 October 2025.Powered by Capital Market - Live
Fabtech Technologies will hold a meeting of the Board of Directors of the Company on 23 October 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 20.73%, vs industry avg of 10.04%
Over the last 5 years, market share increased from 0.05% to 0.08%
Over the last 5 years, net income has grown at a yearly rate of 30.25%, vs industry avg of 20.02%